DePuy Synthes in Brazil: Navigating ANVISA's RDC 751/2022 for Orthopedic Devices

This episode examines the Brazilian market for orthopedic medical devices, using DePuy Synthes (a J&J MedTech company) as a case study. We break down the essential regulatory requirements set by ANVISA, including the pivotal RDC 751/2022 resolution, device classification, the mandatory Brazilian Registration Holder (BRH), and Good Manufacturing Practice (B-GMP) certification. Learn how a global leader successfully navigates one of Latin America's most challenging yet rewarding markets. Key Questions: - What is ANVISA's role in regulating orthopedic devices in Brazil? - How does the RDC 751/2022 resolution impact medical device registration? - What are the four risk classes for medical devices in Brazil, and why do they matter? - Why is a Brazilian Registration Holder (BRH) essential for foreign manufacturers? - What is required to achieve Brazilian Good Manufacturing Practice (B-GMP) certification? - How does DePuy Synthes manage its extensive orthopedic portfolio in the Brazilian market? - Can registration from the US FDA or Health Canada speed up ANVISA approval? - What are the key strategic components for succeeding in Brazil's MedTech sector? Pure Global offers expert regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI tools. From initial strategy and technical dossier submissions to acting as your local representative in over 30 markets, we cover the entire product lifecycle. Our technology-driven approach ensures efficiency and accuracy for startups and multinational enterprises alike. To learn how we can accelerate your entry into markets like Brazil, visit us at https://pureglobal.com/, contact [email protected], or explore our FREE AI tools and database at https://pureglobal.ai/.